Fig. 5From: Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studiesMean actual ECL ratio (anti-HCP antibodies) in (a) INSTRIDE 1 and (b) INSTRIDE 2. Error bars represent the SD. ECL ratio is defined as ECL/ECL at baseline. BL, baseline; ECL, enhanced electrochemiluminescence; HCP, host cell proteinBack to article page